Doxorubicin and Bortezomib in Treating Patients With Liver Cancer

This study is ongoing, but not recruiting participants.

Study NCT00083226 Information provided by Eastern Cooperative Oncology Group

First Received: May 14, 2004 Last Updated: November 12, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	December 2008 (Final data collection date for primary outcome measure)

Publications:

Berlin JD, Powell ME, Su Y, et al.: Bortezomib (B) and doxorubicin (dox) in patients (pts) with hepatocellular cancer (HCC): A phase II trial of the Eastern Cooperative Oncology Group (ECOG 6202) with laboratory correlates. [Abstract] J Clin Oncol 26 (Suppl 15): A-4592, 2008.